The Petitioner, a laboratory supervisor at a biopharmaceutical company, sought to research and develop new drugs for optimizing immune responses and treating immune-related diseases, focusing on T-cell biology and translational immunology.

Prong 1 — national importancenot established

“we need not reach, and therefore reserve the matter of whether his proposed endeavor is of national importance”

“our review of the record indicates that the Petitioner has not demonstrated the national importance of his proposed endeavor”

AAO decision text

Prong 2 — well positionednot established · dispositive

“the Petitioner has not elaborated a model or plan for his future activities, nor has he sufficiently demonstrated interest in collaboration from relevant entities in the United States”

“the Petitioner does not address the Director's observation regarding the absence in the record of independent documentary evidence of these inquiries”

“the record does not show that the Petitioner has received funding for his any future projects”

“he has not sufficiently shown a track record of past success or progress in achieving the proposed endeavor”

“not every individual who has performed original research will be found to be well-positioned to advance his proposed endeavor”

“this is not sufficient to show that he is well-positioned to develop new drugs, therapies, or treatments”

AAO decision text

How the evidence was treated

• recommendation letter · discounted

  “this is not sufficient to show that he is well-positioned to develop new drugs, therapies, or treatments”

  AAO decision text
• citations publications · discounted

  “not every individual who has performed original research will be found to be well-positioned to advance his proposed endeavor”

  AAO decision text
• funding · discounted

  “the record does not show that the Petitioner has received funding for his any future projects”

  AAO decision text
• business plan · discounted

  “the Petitioner has not elaborated a model or plan for his future activities”

  AAO decision text

Where this case turned

• NEW national importance not demonstrated · p1
• Business plan speculative · p2 — projections without a documented basis or steps
• Funding absent · p2 — no documented funding or resources behind the plan
• Letters conclusory · p2 — letters praise skills in general terms without tracing specific impact
• Letters not independent · p2 — letters come from employers and close collaborators, not independent experts
• No progress evidence · p2 — no documented movement toward the endeavor since filing
• Record of success insufficient · p2 — a claimed track record the documents do not establish

Notable

AAO expressly reserved ruling on prong 1 (national importance) but added dicta stating the record did not demonstrate it, instructing the Petitioner to address this in any future motion — an unusual advisory aside despite declining to formally reach the issue.

Authorities this decision leans on

From the doctrinal survivor set — 187 authority tests across 47 distinct authorities cleared the differential-lift gates. Only those appear here.

• 8 C.F.R. 103.3
• 8 C.F.R. 204.5(k)(2)
• Flores v. Garland

Cases in adjacent profiles

• The Petitioner, a senior principal biostatistician, proposes to develop innovative statistical and machine-learning meth
• The Petitioner proposed to use advanced deep learning and machine learning models to create efficient, safe, and well-pe
• The Petitioner proposes to advance machine learning methods for the design and optimization of advanced metamaterials an
• The Petitioner, a postdoctoral chemist, proposed to continue developing high-performance materials and novel synthetic m
• The Petitioner proposes to design novel sensor data processing methods and machine learning algorithms for smart wearabl